Effects of downregulation of SIRT3 expression on proliferation and apoptosis in esophageal squamous cell carcinoma EC9706 cells and its molecular mechanisms

Bio-Medical Materials and Engineering

Volumn 24, Issue 6, 2014, Pages 3883-3890

  Mei, Yang ^a   Chunsong, Yang ^a   Yuhua, Pei ^a  

^a Wuhan City Vocational College   (China)

Author keywords

Apoptosis; Esophageal squamous cell carcinoma; Proliferation; SIRT3; Small interfering RNA

Indexed keywords

CELL PROLIFERATION; PROTEINS;

ESOPHAGEAL SQUAMOUS CELL CARCINOMA; MOLECULAR MECHANISM; PROLIFERATION; PROLIFERATION AND APOPTOSIS; PROLIFERATION INHIBITION; PROTEIN EXPRESSIONS; SIRT3; SMALL INTERFERING RNA;

CELL DEATH;

MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; SIRTUIN 3; SMALL INTERFERING RNA; BAX PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SIRT3 PROTEIN, HUMAN;

APOPTOSIS; CANCER GENE THERAPY; CARCINOMA CELL; CELL INVASION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN DEPLETION; PROTEIN EXPRESSION; WESTERN BLOTTING; ESOPHAGUS TUMOR; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIRTUIN 3;

EID: 84907279861     PISSN: 09592989     EISSN: 18783619     Source Type: Journal    
DOI: 10.3233/BME-141219     Document Type: Conference Paper

References (19)

1. H.J. Weir, J.D. Lane and N. Balthasar SIRT3: A central regulator of mitochondrial adaptation in health and disease, Genes Cancer 4 (2013), 118-124.
2. W.C. Hallows, B.N. Albaugh and J.M. Denu, Where in the cell is SIRT3?-functional localization of an NAD+-dependent protein deacetylase, Biochem. J. 411 (2008), e11-e13.
3. M. Buler, S.M. Aatsinki, V. Izzi et al., Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism, PLoS One 7 (2012), e49863.
4. W.C. Hallows, S. Lee and J.M. Denu, Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases, Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 10230-10235.
5. B.H. Ahn, H.S. Kim, S. Song et al., A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis, Proc. Natl. Acad. Sci. 105 (2008), 14447-14452.
6. N.R. Sundaresan, M. Gupta, G. Kim et al., Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice, J. Clin Invest. 119 (2009), 2758-2771.
7. Y. Chen, L.L. Fu, X. Wen et al., Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer, Cell Death Dis. 5 (2014), e1047.
8. K.H. Huang, C.C. Hsu, W.L. Fang et al., SIRT3 expression as a biomarker for better prognosis in gastric cancer, World J. Surg. 38 (2014), 910-917.
9. T.Y. Alhazzazi, P. Kamarajan, E. Verdin et al., Sirtuin-3 (SIRT3) and the hallmarks of cancer, Genes Cancer 4 (2013), 164-171.
10. T.Y. Alhazzazi, P. Kamarajan, N. Joo, et al., Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer, Cancer 117 (2011), 1670-1678.
11. N. Ashraf, S. Zino, A. Macintyre et al., Altered sirtuin expression is associated with node-positive breast cancer, Br. J. Cancer 95 (2006), 1056-1061.
12. Y. Zhao, H. Yang, X. Wang et al., Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer, Ann. Diagn. Pathol. 17 (2013), 483-485.
13. L. Guarente, Introduction: Sirtuins in aging and diseases, Methods Mol. Biol. 1077 (2013), 3-10.
14. D. Hanahan and R.A. Weinberg, Hallmarks of cancer: The next generation, Cell 144 (2011), 646-674.
15. G. Marfe, M. Tafani, M. Indelicato et al., Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction, J. Cell. Biochem. 106 (2009), 643-650.
16. H. Li, Z. Feng, W. Wu et al., SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2, Int. J. Oncol. 43 (2013), 1420-1430.
17. Y.Y. Zhang and L.M. Zhou, Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation, Biochem. Biophys. Res. Commun. 423 (2012), 26-31.
18. K. Xiao, J. Jiang, W. Wang et al., Sirt3 is a tumor suppressor in lung adenocarcinoma cells, Oncol. Rep. 30 (2013), 1323-1328.
19. P. Kamarajan, T.Y. Alhazzazi, T. Danciu et al., Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis, Cancer 118 (2012), 5800-5810.